(b)(4).Additional information has been requested and will be submitted upon receipt accordingly.The initial medwatch 3500a for this reportable event was timely submitted on (b)(6) 2016 (reference submission core id (b)(4)).The regulatory body date timestamp for acknowledgement 2 was (b)(6) 2016, 19:22:16.Acknowledgement 2 received a status of passed.The regulatory body date timestamp for acknowledgement 3 was fri (b)(6) 19:23:36 edt 2016.Acknowledgement 3 received a status of failed due to ¿input date can not be greater than today.:report identifier:(b)(6) 2016:¿ further inquiry to the fda submission support team at cesub help desk (b)(6) noted that acknowledgement 3 failed due to a difference in time zone.The cesub help desk requested that the medwatch be resubmitted and noted it should pass the validation process.Note: this report will not be reflected as a late mdr on the manufacturer¿s behalf as times zones should not be a concern for timely reporting under mdr.This is one of two reports associated with this event, manufacturer report numbers 1225714-2016-00133 and 1225714-2016-00134.
|
The plaintiff's attorney alleged the patient attended a routine dialysis appointment and thereafter experienced a sudden cardiopulmonary event.The patient was transferred to the hospital and expired approximately three weeks later.Further information noted prior to the patient's demise, on four separate occasions, the patient had experienced adverse reactions and was hospitalized on each occasion.
|